Improve Parkinson care via telemedicine
- Trial ID
- NCT06479083
- Official Title
- Interdisciplinary and Intersectoral Telemedicine Evaluation, Coordination and Treatment in the Rhine Main+ Parkinson's Network
- Goal
- Improve Parkinson care via telemedicine
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- Johannes Gutenberg University Mainz
- Study Type
- INTERVENTIONAL
- Enrollment
- 1354 participants
- Conditions
- Parkinson Disease
- Interventions
- New Intervention form including, Standard treatment
Plain-Language Summary
The goal is to make specialist Parkinson's care easier to reach and better coordinated across the Rhine-Main region, so symptoms, medications and therapies can be reviewed and adjusted more quickly and consistently. The approach uses an interdisciplinary telemedicine package,video visits with neurologists, structured medication reviews, and coordinated referrals with shared electronic care plans,so teams can optimize levodopa and other treatments, manage side effects, and arrange local therapy without changing how the drugs work. Adults 30 to 85 years old living in Hesse or Rhineland-Palatinate with Parkinson's or atypical Parkinsonism who can give consent are eligible, while people with severe dementia, major psychiatric illness, active addiction, pregnancy, insufficient language skills, or participation in another interventional treatment trial are excluded.
Locations
- Universtity of Saarland, Campus Homburg, Dept. of Neurology, Homburg, Germany
- INSPIRE-PNRM+ Neuroimaging Center (NIC) University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany
Frequently Asked Questions
- What is this trial testing?
- This trial is studying New Intervention form including. The goal is to make specialist Parkinson's care easier to reach and better coordinated across the Rhine-Main region, so symptoms, medications and therapies can be reviewed and adjusted more quickly and consistently. The approach uses an interdisciplinary telemedicine package,video visits with neurologists, structured medication reviews, and coordinated referrals with shared electronic care plans,so teams can optimize levodopa and other treatments, manage side effects, and arrange local therapy without changing how the drugs work. Adults 30 to 85 years old living in Hesse or Rhineland-Palatinate with Parkinson's or atypical Parkinsonism who can give consent are eligible, while people with severe dementia, major psychiatric illness, active addiction, pregnancy, insufficient language skills, or participation in another interventional treatment trial are excluded.
- Who can participate?
- Participants must be between 30 Years and 85 Years.
- Where is this trial located?
- This trial is recruiting at 2 locations.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 1 year and 4 months.